ZA200707970B - Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis - Google Patents
Compositions of HSP60 peptides and viral antigens for vaccination and diagnosisInfo
- Publication number
- ZA200707970B ZA200707970B ZA200707970A ZA200707970A ZA200707970B ZA 200707970 B ZA200707970 B ZA 200707970B ZA 200707970 A ZA200707970 A ZA 200707970A ZA 200707970 A ZA200707970 A ZA 200707970A ZA 200707970 B ZA200707970 B ZA 200707970B
- Authority
- ZA
- South Africa
- Prior art keywords
- vaccination
- diagnosis
- compositions
- viral antigens
- hsp60 peptides
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6043—Heat shock proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66101705P | 2005-03-14 | 2005-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200707970B true ZA200707970B (en) | 2008-11-26 |
Family
ID=36992117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200707970A ZA200707970B (en) | 2005-03-14 | 2006-02-21 | Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis |
Country Status (7)
Country | Link |
---|---|
US (3) | US20080279878A1 (fr) |
EP (2) | EP1858548B1 (fr) |
AU (1) | AU2006224216B2 (fr) |
CA (1) | CA2601518A1 (fr) |
ES (1) | ES2389849T3 (fr) |
WO (1) | WO2006097914A2 (fr) |
ZA (1) | ZA200707970B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8414899B2 (en) * | 2006-04-11 | 2013-04-09 | Yeda Research And Development Co. Ltd. | Vaccines comprising multimeric HSP60 peptide carriers |
US9345753B2 (en) | 2008-01-16 | 2016-05-24 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Vaccine for alzheimer's disease |
GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
PH12013000059A1 (en) * | 2013-02-15 | 2016-12-12 | Yu Gracia Fe | Diagnosis and detection of dengue virus infection using chicken egg antibodies |
CN103880962B (zh) * | 2014-03-19 | 2016-01-06 | 国家纳米科学中心 | 融合蛋白及其编码基因和制备方法以及一种药物组合物及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4073943A (en) | 1974-09-11 | 1978-02-14 | Apoteksvarucentralen Vitrum Ab | Method of enhancing the administration of pharmalogically active agents |
US4168308A (en) * | 1976-03-12 | 1979-09-18 | Apoteksvarucentralen Vitrum Ab | Composition for enhancing the administration of pharmacologically active agents |
NL8701163A (nl) | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
NL8703107A (nl) | 1987-12-22 | 1989-07-17 | Nederlanden Staat | Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten. |
US5114844A (en) | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
US5736146A (en) * | 1992-07-30 | 1998-04-07 | Yeda Research And Development Co. Ltd. | Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
US5961970A (en) | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
US5869058A (en) | 1994-05-25 | 1999-02-09 | Yeda Research And Development Co. Ltd. | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
IL109790A0 (en) * | 1994-05-25 | 1994-08-26 | Yeda Res & Dev | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
US7790158B2 (en) * | 2001-09-25 | 2010-09-07 | The Regents Of The University Of California | Methods for epitope-specific and cytokine/anticytokine combination immunotherapies |
WO2002062959A2 (fr) * | 2001-02-05 | 2002-08-15 | Stressgen Biotechnologies Corp. | Traitement du virus de l'hepatite b |
AU2003263853A1 (en) * | 2002-08-16 | 2004-03-03 | Board Of Regents The University Of Texas System | Compositions and methods related to flavivirus envelope protein domain iii antigens |
-
2006
- 2006-02-21 EP EP06711204A patent/EP1858548B1/fr not_active Not-in-force
- 2006-02-21 CA CA002601518A patent/CA2601518A1/fr not_active Abandoned
- 2006-02-21 EP EP11165324.2A patent/EP2402022B1/fr not_active Not-in-force
- 2006-02-21 AU AU2006224216A patent/AU2006224216B2/en not_active Ceased
- 2006-02-21 US US11/908,474 patent/US20080279878A1/en not_active Abandoned
- 2006-02-21 WO PCT/IL2006/000222 patent/WO2006097914A2/fr active Application Filing
- 2006-02-21 ES ES06711204T patent/ES2389849T3/es active Active
- 2006-02-21 ZA ZA200707970A patent/ZA200707970B/xx unknown
-
2011
- 2011-06-20 US US13/164,411 patent/US8652439B2/en not_active Expired - Fee Related
-
2014
- 2014-01-02 US US14/146,549 patent/US20140120126A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2402022B1 (fr) | 2014-10-29 |
WO2006097914A3 (fr) | 2007-01-04 |
EP2402022A2 (fr) | 2012-01-04 |
US20080279878A1 (en) | 2008-11-13 |
US20110256165A1 (en) | 2011-10-20 |
EP2402022A3 (fr) | 2012-04-25 |
EP1858548A2 (fr) | 2007-11-28 |
AU2006224216A1 (en) | 2006-09-21 |
US8652439B2 (en) | 2014-02-18 |
AU2006224216B2 (en) | 2011-12-08 |
EP1858548B1 (fr) | 2012-06-20 |
EP1858548A4 (fr) | 2009-03-11 |
ES2389849T3 (es) | 2012-11-02 |
CA2601518A1 (fr) | 2006-09-21 |
WO2006097914A2 (fr) | 2006-09-21 |
US20140120126A1 (en) | 2014-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2089053A4 (fr) | Compositions vaccinales a base de proteine de fusion de l'antigene hpv et utilisations de celles-ci | |
HRP20170024T1 (hr) | Antigeni peptidi gm-csf i protutijela protiv gm-csf | |
HK1211606A1 (en) | Identification of tumor-associated antigens for diagnosis and therapy | |
ZA200810456B (en) | Lyophilized formulations of anti-EGFR antibodies | |
EP1984405A4 (fr) | Antigenes de la grippe, compositions de vaccins et procedes associees | |
ZA201002160B (en) | Human gm-csf antigen binding proteins | |
IL193397A0 (en) | Hpv antigens, vaccine compositions, and related methods | |
EP1948227A4 (fr) | Vaccin a antigene combinatoire contre la grippe | |
EP2006377A4 (fr) | Nouveaux peptides antigènes tumoraux | |
AU2003246373A8 (en) | Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions | |
PL1890720T3 (pl) | Kompozycje farmaceutyczne zawierające peptydy pochodzące z kazeiny i sposoby ich stosowania | |
IL205398A0 (en) | New antibodies specific of the ?? - amyloid peptides and their uses as diagnostic agents or drugs | |
EP1934335A4 (fr) | Particules virus mosaique du tabac modifiées utilisées comme supports pour la disposition d'antigènes protéiques pour des applications de vaccins | |
HK1219052A1 (zh) | 針對典型性豬瘟病毒的嵌合疫苗抗原 | |
ZA200707970B (en) | Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis | |
ZA200805198B (en) | Pro-apoptotic bacteria and compositions for delivery and expression of antigens | |
EP1871786A4 (fr) | Vaccin peptidique contre la grippe | |
ZA201101743B (en) | Vaccine comprising protein nmbo964 from meisseria meningitidis | |
ZA200803664B (en) | Chimeric antigens and vaccines | |
IL185932A0 (en) | Compositions of hsp60 peptides and viral antigers for vaccination and diagnosis | |
EP2024538A4 (fr) | Compositions et methodes pour identifier des antigenes | |
ZA200710374B (en) | Pharmaceutical compositions comprising casein derived peptides and methods of use thereof | |
IL185772A0 (en) | Antigen specific lymphocytes, compositions thereof, and methods for isolation and preparation thereof | |
IL222485A (en) | Medical preparations that contain peptide-derived peptides and methods for their use | |
IL187120A0 (en) | Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |